Author's details
- Dr. Khashau Eleburuike
- MBBS (Ilorin) MSc. Global Health Karolinska Institute.
- Resident doctor in family medicine in Northern Sweden.
Reviewer's details
- Dr Gboyega Olarinoye
- MBBS, FMCP.
- Dermatologist at FMC Keffi Nassarawa State. Nigeria
Cutaneous Cryptococcosis
Background
Cutaneous cryptococcosis in darker-skinned individuals may present with nodules, ulcers, or plaques that can be harder to identify due to skin tone. It is often associated with immunosuppression, such as in HIV patients, and may mimic other skin conditions. Treatment typically involves antifungal therapy, such as fluconazole or amphotericin B, depending on the severity and immune status of the patient.
References
- Hay RJ, Ashbee HR: Cryptococcosis. In Rook’s textbook of dermatology 9th ed. (Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D ed), pp. 32, 92-93, Wiley-Blackwell, Oxford, 2016.
- Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kusuhara M, Ihn H. Cutaneous cryptococcosis. Medical mycology journal. 2019;60(4):101-7.
- Lu Y, Wu C, Hong C. Primary cutaneous cryptococcosis in an immunocompetent man: A case report. 2013;31(2):90-93.